Last reviewed · How we verify
SEA-TGT — Competitive Intelligence Brief
discontinued
solution in vials
Oncology
Live · refreshed every 30 min
Target snapshot
SEA-TGT (sea-tgt) — Pfizer Inc.. solution in vials
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SEA-TGT TARGET | sea-tgt | Pfizer Inc. | discontinued | solution in vials |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (solution in vials class)
- Pfizer Inc. · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SEA-TGT CI watch — RSS
- SEA-TGT CI watch — Atom
- SEA-TGT CI watch — JSON
- SEA-TGT alone — RSS
- Whole solution in vials class — RSS
Cite this brief
Drug Landscape (2026). SEA-TGT — Competitive Intelligence Brief. https://druglandscape.com/ci/sea-tgt. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing